Sino Biological's gene synthesis and cell-free protein expression technology was used by Tencent AI for Life Sciences Lab to rapidly validate AI-designed proteins with enhanced activity, stability, and multifunctionality. Their XPressMAX™ Cell-Free Protein Synthesis Kit enabled fast protein expression and functional screening, allowing the team to engineer proteins with significantly improved performance, such as a lysozyme with 100-fold higher activity and a thermostable chitinase active at 85°C. This advancement bridges the gap between AI protein design and experimental validation, accelerating protein engineering and potential biotech applications.
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
Alibaba and Baidu shares rose after Apple received approval from China's Cyberspace Administration to include Apple Intelligence, integrating Alibaba's Qwen AI model and Baidu's AI features into Apple devices in China. This partnership allows users t...
Ondo Finance has introduced the first tokenized stock representations backed by DTCC tokenized entitlements, joining major financial firms in a significant tokenization initiative. This move highlights Ondo's unique position in building infrastructur...
Leading Japanese companies, startups, and research institutions are developing specialized AI models using NVIDIA Nemotron open models to address Japan's unique language, industrial, and workforce challenges. These AI applications range from enterpri...
